
Patent Law Weblog
recent posts
- USPTO Requires Foreign-domiciled Patent Applicants and Owners to Be Represented by USPTO-registered Practitioners
- Extremity Medical, LLC v. Nextremity Solutions, Inc. (Fed. Cir. 2026)
- PTAB § 101 Affirmance Rates Dip under Director Squires
- In re Magnolia Medical Technologies, Inc. (Fed. Cir. 2026)
- Improving the Abstract Idea: How a Rhetorical Move Undermines § 101 Analysis of Technical Improvements in Software Inventions
about
Day: July 1, 2012
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Cumberland Pharmaceuticals Inc. v. Sagent Agila LLC et al.1:12-cv-00825; filed June 26, 2012 in the District Court of Delaware • Plaintiff: Cumberland Pharmaceuticals Inc.• Defendants: Sagent Agila LLC; Sagent Pharmaceuticals Inc. Infringement of U.S. Patent…
-
July 11-13, 2012 – Fundamentals of Patent Prosecution 2012: A Boot Camp for Claim Drafting & Amendment Writing (Practising Law Institute) – San Francisco, CA July 12, 2012 – Inducement to Infringe in Hatch-Waxman Litigation: Lessons from Bayer Schering v. Lupin and AstraZeneca v. Apotex for Pharma Patents (Strafford) – 1:00 – 2:30 pm (EDT)…